Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News on Pharma

Opioid maker Endo paid top executives $55.5 million in bonuses before bankruptcy

Days before the money-losing opioid drug firm Endo International filed for bankruptcy last week, the company paid chief executive Blaise Coleman an $11.85 million bonus.

The Philadelphia Inquirer

US House panel slams Trump’s COVID response; report mentions early role from Mehmet Oz

Mehmet Oz’s advocacy for the drug hydroxychloroquine in the early days of the COVID-19 pandemic is cited in a new congressional report that accuses former President Donald Trump’s administration of pressuring the Food and Drug Administration to endorse unproven treatments and vaccines.

The Philadelphia Inquirer

Study: Pfizer COVID pill showed no benefit in younger adults

Pfizer’s COVID-19 pill appears to provide little or no benefit for younger adults

The Independent UK

From analysis to the latest developments in health,
read the most diverse news in one place.

Trump officials tried to ‘bully’ FDA over Covid treatments, House panel says

Congressional investigation finds new evidence of efforts to override health decisions early in pandemic

The Guardian - US

Psychedelic-Based Cocaine Addiction Treatment Study Showing Positive Results. This Is What We Know

Israeli-Canadian biotech psychedelics developer Clearmind Medicine Inc. (OTC Pink: CMNDF) together with clinical-stage cannabinoid pharma company SciSparc Ltd.

Benzinga

Advocates urge FDA action to ease policing fears in menthol ban

WASHINGTON — Experts and advocates are calling on the Biden administration to do more to avoid potential confrontations between police and racial minorities if the Food and Drug Administration finalizes a ban on menthol cigarettes.

Tribune News Service

Cornell University And Thai Leaf Collaborate To Design New Hemp And CBD Strains In Thailand

Thai Leaf Biotechnology, a private company in the hemp industry, and Cornell University will collaborate in the design and development of new hemp strains that are high in CBD and adapted to Thailand’s weather. The initiative seeks to “upgrade the Thai hemp market,”

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Algernon Pharmaceuticals Closes Private Placement Round, Announces New Shareholder Distribution

Biotech clinical-stage company Algernon Pharmaceuticals Inc.

Benzinga

DEA Psychedelic Drugs Banning Attempt: These Are The Two Hallucinogens Under Discussion

The DEA recently abandoned a proposal for placing five tryptamines as Schedule I under the Controlled Substances Act.

Benzinga

3 Biotech Penny Stocks to Avoid

The biotech industry thrived during the pandemic. However, that seems to be fading as the pandemic situation has relaxed. And given the inherent volatility of penny stocks, iBio (IBIO), VistaGen Therapeutics (VTGN), and Timber Pharmaceuticals (TMBR) might be best avoided amid the broader market turmoil. Read more….

StockNews.com

Pfizer COVID shots appear 73% effective in children under 5

Pfizer’s says its COVID-19 vaccine was 73% effective in protecting children younger than 5 as omicron spread in the spring

The Independent UK

Viva Biotech Dispenses Bitter Pill of Slowing Growth, Asset Devaluation

Key Takeaways: Viva Biotech’s eked out a scant 5% revenue growth in the first half of the year and fell into the red, even as other peers in China’s CXO sector performed much better Changing values of the company’s investments are largely behind big fluctuations in its performance in recent…

Benzinga

Pfizer’s shot is 73% effective against COVID in children under 5

Pfizer Inc.’s COVID-19 vaccine was 73.2% effective against the disease in a trial of children 6 months through 4 years old, reinforcing results that led to the shot’s authorization in young kids in June.

Tribune News Service

Freedom Biosciences Gets $10.5M In Seed Financing For Psychedelics Research, This Is What We Know

Freedom Biosciences achieved a major $10.5 million in a seed financing round in which MBX Capital, PsyMed Ventures, Village Global and The Yale Startup, among others, participated.

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

ABC News

Pharmacist prescription trial proposed as possible solution to the GP shortage faces indefinite delays

Some Australians are waiting longer than ever to see their GP, and one state has come up with a possible solution that would allow pharmacists to take over some of the doctors' prescription work. But a trial that was due to begin in June has now been delayed, with no…

Bangkok Post

Thai Leaf, Cornell team up on hemp

Thai Leaf Biotechnology, a private company that imports and produces hemp seed, in collaboration with Cornell University, has unveiled plans to upgrade the Thai hemp market by developing new strains of hemp and seeds that are suitable to be grown in Thailand's climate as well as yielding a high cannabidiol…

The Independent UK

Congo reports new Ebola case linked to previous outbreak

Congo's health ministry has confirmed a new Ebola case in Congo’s eastern Beni city and say it was linked to a previous outbreak

Tribune News Service

Pfizer files application for booster against latest variants

Pfizer Inc. and BioNTech SE asked the U.S. to authorize a new COVID-19 booster shot customized against the currently circulating COVID-19 variants as governments race to protect their populations against the ever-mutating virus.

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

What's Next For The 20-Year Old Behind $100M Bed Bath & Beyond Trade? Why Jake Freeman Is Focused On This Psychedelics Stock

Bed Bath & Beyond (NASDAQ: BBBY) traders learned last week about Jake Freeman, the 20-year University of Southern California student investor who outsmarted the entire class of "Ape" investors, including GameStop Corp. (NYSE:

WEKU

Pfizer asks FDA to greenlight new omicron booster shots, which could arrive this fall

Pfizer has submitted data on its bivalent COVID-19 booster shot that specifically targets the latest omicron subvariants. If authorized, the company says the shots could be ready as soon as September.

The Independent UK

FTSE 100 chief executive average pay jumps by 39% to £3.4m

“To see CEO pay rocketing to more than 100 times the average salary is sickening,” say union bosses

The Independent UK

Pfizer seeks OK of updated COVID vaccine booster for fall

Pfizer has asked U.S. regulators to authorize its combination COVID-19 vaccine that adds protection against the newest omicron relatives

The Guardian - AU

Fentanyl seizure: experts warn potent drug could rapidly emerge as a problem in Australia

Experts say news of record haul of more than 11kg of the opioid drug, found in February, should have been announced sooner

ABC News

Why are federal authorities so concerned about a record fentanyl shipment found in Melbourne?

After a record amount of fentanyl was seized in Melbourne, authorities are sounding the alarm about the highly dangerous drug that has rarely been found in Australia.

ABC News

AFP, ABF discover record fentanyl seizure in machinery sent from Canada to Melbourne

Federal authorities have intercepted a record amount of the potentially deadly opioid fentanyl, hidden inside machinery sent to Melbourne.

1 … 136 137 138 139

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Food and Drug Administration

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.